Eucrisa

Chemical Namecrisaborole
Dosage FormOintment (topical; 2%)
Drug ClassInhibitors
SystemSkin
CompanyAnacor Pharms Inc.
Approval Year2016

Indication

  • For topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
Last updated on 12/23/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Eucrisa (crisaborole) Prescribing Information 2020Pfizer Labs, NY NY